Cobalt Becomes Watson

On December 2, 2009, the Arrow Group, including Cobalt Laboratories, was acquired by Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading U.S. based global specialty pharmaceutical company with approximately $3 billion in revenues, a broad product line and operations in well-established and emerging markets.

Cobalt’s U.S. business is now a part of Watson. For more information, visit Watson.com or call 1-800-272-5525.